• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.23% Nasdaq Up0.11%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    0.39 Up 0.01(1.39%) 12:59PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 1,008   538   491   152  
    Cost of Revenue253  148  297  41  
    Gross Profit 755   390   194   111  
    Operating Expenses
    Research Development1,245  1,641  2,433  2,312  
    Selling General and Administrative4,369  3,410  2,662  1,912  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,859) (4,661) (4,901) (4,113)
    Income from Continuing Operations
    Total Other Income/Expenses Net(22)23  425  (106)
    Earnings Before Interest And Taxes(4,881)(4,638)(4,476)(4,219)
    Interest Expense -   -   -   -  
    Income Before Tax(4,881)(4,638)(4,476)(4,219)
    Income Tax Expense6  2  (8) -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(4,887)(4,640)(4,468)(4,219)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (4,887) (4,640) (4,468) (4,219)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (4,887) (4,640) (4,468) (4,219)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.